Susan Thornton
General Counsel at GALECTIN THERAPEUTICS INC.
Profile
Susan Thornton is currently the Vice President of Regulatory Affairs at Galectin Therapeutics, Inc. She previously held positions as the Director of Regulatory Affairs at Aptalis Pharma LLC, Vice President of Regulatory Affairs at Antares Pharma, Inc., and Vice President of Regulatory Affairs at Strongbridge Biopharma Plc.
Ms. Thornton received a graduate degree from Temple University (Pennsylvania) and an undergraduate degree from Rider University.
Susan Thornton active positions
| Companies | Position | Start |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | General Counsel | - |
Former positions of Susan Thornton
| Companies | Position | End |
|---|---|---|
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | General Counsel | - |
| STRONGBRIDGE BIOPHARMA | General Counsel | - |
| ANTARES PHARMA, INC. | General Counsel | - |
Training of Susan Thornton
| Temple University (Pennsylvania) | Graduate Degree |
| Rider University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GALECTIN THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Health Technology |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Stock Market
- Insiders
- Susan Thornton
